TITLE

Ongoing HIV dissemination during HAART

AUTHOR(S)
Grossman, Zvi; Polis, Michael; Feinberg, Mark B.; Grossman, Zehava; Levi, Itschak; Jankelevich, Shirley; Yarchoan, Robert; Boon, Jacob; de Wolf, Frank; Lange, Joep M.A.; Goudsmit, Jaap; Dimitrov, Dimiter S.; Paul, William E.
PUB. DATE
October 1999
SOURCE
Nature Medicine;Oct1999, Vol. 5 Issue 10, p1099
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines a model of HIV replication which occurs in multiple local bursts. Association with immune activation in response to antigens; Effects of anti-retroviral drugs on the size of the bursts; Implications for HIV treatment.
ACCESSION #
8818441

 

Related Articles

  • Human Immunodeficiency Virus Type 1-Infected Persons with Residential Disease and Virus Reservoirs on Suppressive Highly Active Antiretroviral Therapy Can Be Stratified into Relevant Virologic and Immunological Subgroups. Dornadula, Geethanjali; Nunnari, Giuseppe; Vanella, Michelle; Roman, Jeanette; Babinchak, Timothy; DeSimone, Joseph; Stern, John; Braffman, Michael; Zhang, Hui; Pomerantz, Roger J. // Journal of Infectious Diseases;6/1/2001, Vol. 183 Issue 11, p1682 

    Presents information on a study which determined HIV-1 replication among infected persons undergoing highly active antiretroviral therapy. Methodology; Results of the study; Discussion.

  • Identification of Authentic Inhibitors of HIV-1 Integration. Witvrouw, M.; Fikkert, V.; Vercammen, J.; Van Maele, B.; Engelborghs, Y.; Debyser, Z. // Current Medicinal Chemistry - Anti-Infective Agents;Apr2005, Vol. 4 Issue 2, p153 

    Current strategies for the treatment of human immunodeficiency virus (HIV) infection are based on cocktails of drugs that target the viral entry step and the enzymes reverse transcriptase or protease. At present, the clinical benefit of this combination therapy for HIV-infected patients is...

  • The pathogenesis of HIV infection: stupid may not be so dumb after all. Smith, Stephen M. // Retrovirology;2006, Vol. 3, p60 

    In the mid-1990's, researchers hypothesized, based on new viral load data, that HIV-1 causes CD4+ T-cell depletion by direct cytopathic effect. New data from non-human primate studies has raised doubts about this model of HIV-1 pathogenesis. Despite having high levels of viremia, most SIV...

  • Preventing and Managing Antiretroviral Drug Resistance. Kuritzkes, Daniel R. // AIDS Patient Care & STDs;May2004, Vol. 18 Issue 5, p259 

    Development of resistance to antiretroviral drugs (ARVs) is a major impediment to optimum treatment of HIV-1 infection. Although resistance testing can help to select subsequent regimens when virologic failure occurs, cross-resistance, which affects all classes of ARVs, may make it more...

  • A Pilot Study of Health Beliefs and Attitudes Concerning Measures of Antiretroviral Adherence Among Prisoners Receiving Directly Observed Antiretroviral Therapy. White, Becky L.; Wohl, David A.; Hays, Ron D.; Golin, Carol E.; Liu, Honghu; Kiziah, C. Nichole; Simpson, Gregory; Kaplan, Andrew H. // AIDS Patient Care & STDs;Jun2006, Vol. 20 Issue 6, p408 

    High level adherence to antiretroviral therapy (ART) is required to achieve and maintain suppression of HIV replication. Although directly observed therapy (DOT) has been suggested as an intervention to improve adherence, there is a paucity of data describing the attitudes and beliefs regarding...

  • Pharmacokinetic enhancement of protease inhibitor therapy. King, Jennifer R.; Wynn, Heather; Brundage, Richard; Acosta, Edward P. // Clinical Pharmacokinetics;2004, Vol. 43 Issue 5, p291 

    Combination antiretroviral therapy with two or more protease inhibitors has become the standard of care in the treatment of HIV infection. Dual protein inhibitor (PI) regimens, such as lopinavir/ritonavir, are commonly used as initial PI therapy. As viral resistance increases and the development...

  • Green tea and HIV.  // Life Extension;Nov2002, Vol. 8 Issue 11, p74 

    Studies the effects of epigallocatechin-3-gallate (EGCG), a component of green tea, on HIV infection. Inhibition of virus replication.

  • Microbial translocation linked to immune activation in HIV-infected children. Stott, Bob; Zacharyczuk, Colleen // Infectious Disease News;Mar2012, Vol. 25 Issue 3, p22 

    The article reports on a research which examined whether gut microbial translocation represented a major stimulus for immune activation that persisted after control of virus replication in HIV-infected children.

  • HIV: A higher hurdle to eliminate HIV? Harrison, Charlotte // Nature Reviews Drug Discovery;Jan2014, Vol. 13 Issue 1, p20 

    The article discusses research being done on barriers to eliminate HIV, which references the study "Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure," by Y-. C. Ho.

  • HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Altfeld, Marcus; Allen, Todd M.; Yu, Xu G.; Johnston, Mary N.; Agrawal, Deepak; Korber, Bette T.; Montefiori, David C.; O'Connor, David H.; Davis, Ben T.; Lee, Paul K.; Maier, Erica L.; Harlow, Jason; Goulder, Philip J. R.; Brander, Christian; Rosenberg, Eric S.; Walker, Bruce D. // Nature;11/28/2002, Vol. 420 Issue 6914, p434 

    Early treatment of acute HIV-1 infection followed by treatment interruptions has shown promise for enhancing immune control of infection. A subsequent loss of control, however, allows the correlates of protective immunity to be assessed. Here we show that sudden breakthrough of plasma viraemia...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics